The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Preventive Medicine

Background:

• Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac disease.
• Historically, HCM had a poor prognosis and was a leading cause of sudden cardiac death (SCD) in young individuals.
• Recent advancements have transformed HCM into a treatable condition with improved management strategies.

Purpose of the Study:

• To highlight the shift in understanding HCM from an untreatable to a treatable disease.
• To emphasize the impact of implantable cardioverter-defibrillators (ICDs) on managing SCD risk in HCM.
• To discuss current risk stratification methods for prophylactic ICD implantation.

Main Methods:

• Review of clinical practice and therapeutic advances in HCM management.
• Analysis of the role of implantable cardioverter-defibrillators in preventing SCD.
• Evaluation of guideline-based risk stratification algorithms, including those incorporating cardiac magnetic resonance imaging (CMR).
• Comparison of traditional risk marker strategies with newer mathematical risk scores for ICD decision-making.

Main Results:

• ICDs have enabled primary prevention of SCD in HCM by terminating ventricular tachyarrhythmias, reducing annual mortality by over 10-fold to 0.5%.
• Guideline-based risk stratification, incorporating clinical factors and CMR findings, aids in recommending prophylactic ICDs.
• The ACC/AHA risk marker strategy shows 95% sensitivity for identifying patients needing appropriate ICD therapy, though often years after implantation.
• The ESC mathematical SCD risk score has lower sensitivity (33%) but may reduce device overtreatment.

Conclusions:

• HCM is now a treatable condition with significantly improved outcomes due to advances like ICDs.
• Effective risk stratification is crucial for guiding prophylactic ICD implantation in HCM patients at high risk for SCD.
• Shared decision-making, incorporating physician judgment and patient factors, is essential for optimal management of HCM and SCD prevention.